Ambu AuraGain and Teleflex LMA Protector Fiberoptic Assessments in Elective Patients
Randomized Comparison of Ambu AuraGain and Teleflex Protector Using Clinical and Fiberoptic Assessments in Elective Patients
Sponsor: Ambu A/S
Listed as NCT02724956, this NA trial focuses on Anesthesia and remains completed. Sponsored by Ambu A/S, it has been updated 17 times since 2017, reflecting substantial change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
17 versions recorded-
Sep 2024 — Present [monthly]
Completed NA
-
Jul 2024 — Sep 2024 [monthly]
Completed NA
-
Oct 2021 — Jul 2024 [monthly]
Completed NA
-
Sep 2021 — Oct 2021 [monthly]
Completed NA
-
Feb 2021 — Sep 2021 [monthly]
Completed NA
Status: Active Not Recruiting → Completed
▶ Show 12 earlier versions
-
Jan 2021 — Feb 2021 [monthly]
Active Not Recruiting NA
-
Sep 2020 — Jan 2021 [monthly]
Active Not Recruiting NA
-
Feb 2020 — Sep 2020 [monthly]
Active Not Recruiting NA
-
Jan 2020 — Feb 2020 [monthly]
Active Not Recruiting NA
-
Jul 2019 — Jan 2020 [monthly]
Active Not Recruiting NA
Status: Recruiting → Active Not Recruiting
-
Jun 2019 — Jul 2019 [monthly]
Recruiting NA
-
Jun 2018 — Jun 2019 [monthly]
Recruiting NA
-
Dec 2017 — Jun 2018 [monthly]
Recruiting NA
Status: Not Yet Recruiting → Recruiting
-
Nov 2017 — Dec 2017 [monthly]
Not Yet Recruiting NA
-
Apr 2017 — Nov 2017 [monthly]
Not Yet Recruiting NA
Status: Withheld → Not Yet Recruiting
-
Feb 2017 — Apr 2017 [monthly]
Withheld NA
-
Jan 2017 — Feb 2017 [monthly]
Withheld NA
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Ambu A/S
- M.D. Anderson Cancer Center
For direct contact, visit the study record on ClinicalTrials.gov .